NME2 reduces proliferation, migration and invasion of gastric cancer cells to limit metastasis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Liu, Yan Fei ^a,b   Yang, Aijun ^a   Liu, Wei ^a   Wang, Chenyu ^a   Wang, Min ^a   Zhang, Lihan ^a   Wang, Dongcang ^a   Dong, Jing Fei ^c,d   Li, Min ^a  

^a LANZHOU UNIVERSITY   (China)

^b Xi'an Gaoxin Hospital   (China)

^c PUGET SOUND BLOOD CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; NUCLEOSIDE DIPHOSPHATE KINASE 2; PHOSPHOTRANSFERASE; RNA; UNCLASSIFIED DRUG; NME2 PROTEIN, HUMAN; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

ADULT; ARTICLE; BGC823 CELL LINE; CANCER CELL; CANCER TISSUE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GASTRIC CANCER CELL LINE; GENE PRODUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MKN45 CELL LINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH CANCER; ADENOCARCINOMA; CELL MOTION; ENZYMOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; STOMACH NEOPLASMS;

EID: 84923683699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115968     Document Type: Article

References (37)

1. WHO:Globocan 2012, IARC http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx
2. WHO:cancer, http://www.who.int/mediacentre/factsheets/fs297/en/
3. WHO: Globocan 2012, http://globocan.iarc.fr/Pages/fact-sheets-population.aspx
4. Boissan M, Dabernat S, Peuchant E, Schlattner U, Lascu I, et al. (2009) The mammalian Nm23/NDPK family: from metastasis control to cilia movement. Molecular and cellular biochemistry 329: 51-62. doi: 10.1007/s11010-009-0120-7 PMID: 19387795
5. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, et al. (1988) Evidence for a novel gene associated with low tumor metastatic potential. Journal of the National Cancer Institute 80: 200-204. PMID: 3346912
6. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, et al. (1991) Identification of a second human nm23 gene, nm23-H2. Cancer research 51: 445-449. PMID: 1988104
7. Godfried MB, Veenstra M, SLUIS PV, Boon K, ASPEREN RV, et al. (2002) The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21: 2097-2101. PMID: 11960382
8. Hennessy C, Henry JA, May FE, Westley BR, Angus B, et al. (1991) Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. Journal of the National Cancer Institute 83: 281-285. PMID: 1994057
9. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland ØS, et al. (1992) Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer research 52: 6088-6091. PMID: 1356624
10. Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M (2000) Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Human pathology 31: 709-716. PMID: 10872665
11. Leone A, Seeger R, Hong C, Hu Y, Arboleda M, et al. (1993) Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8: 855. PMID: 8384356
12. Watanabe J, Sato Y, Kuramoto H, Kameya T (1995) Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma. British journal of cancer 72: 1469. PMID: 8519661
13. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K, et al. (1995) NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer research 55: 652-657. PMID: 7530600
14. Arai T, Watanabe M, Onodera M, Yamashita T, Masunaga A, et al. (1993) Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. The American journal of pathology 142: 1938. PMID: 8389529
15. Rajan N, Habermehl J, Coté M- F, Doillon CJ, Mantovani D (2007) Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nature protocols 1: 2753-2758.
16. Marone M, Scambia G, Ferrandina G, Giannitelli C, Benedetti-Panici P, et al. (1996) Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. British journal of cancer 74: 1063. PMID: 8855975
17. Thakur RK, Yadav VK, Kumar P, Chowdhury S (2011) Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types. Naunyn Schmiedebergs Arch Pharmacol 384: 397-406. doi: 10.1007/s00210-011-0631-0 PMID: 21556888
18. Huang B, Sun L, Cao J, Zhang Y, Wu Q, et al. (2013) Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells. Oncology reports.
19. Chen D, Zhang R, Shen W, Fu H, Liu S, et al. (2013) RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector. International journal of oncology.
20. Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, et al. (1997) Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infection and immunity 65: 3218-3224. PMID: 9234778
21. Saitoh T, Kirikoshi H, Mine T, Katoh M (2001) Proto-oncogene WNT10B is up-regulated by tumor necrosis factor a in human gastric cancer cell line MKN45. International journal of oncology 19: 1187-1192. PMID: 11713588
22. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, et al. (1991) Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells. Cell 65: 25-35. PMID: 2013093
23. Leone A, Flatow U, VanHoutte K, Steeg P (1993) Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325. PMID: 8395676
24. Baba H, Urano T, Okada K, Furukawa K, Nakayama E, et al. (1995) Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer research 55: 1977-1981. PMID: 7728768
25. Parhar RS, Shi Y, Zou M, Farid NR, Ernst P, et al. (1995) Effects of cytokine?mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. International journal of cancer 60: 204-210. PMID: 7829217
26. Fukuda M, Ishii A, Yasutomo Y, Shimada N, Ishikawa N, et al. (1996) Decreased expression of nucleoside diphosphate kinase α isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary?adenocarcinoma cells. International journal of cancer 65: 531-537. PMID: 8621239
27. Tagashira H, Hamazaki K, Tanaka N, Gao C, Namba M (1998) Reduced metastatic potential and cmyc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform. International journal of molecular medicine 2: 65. PMID: 9854145
28. Miyazaki H, Fukuda M, Ishijima Y, Takagi Y, Iimura T, et al. (1999) Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clinical cancer research 5: 4301-4307. PMID: 10632374
29. Lee M-J, Xu D-Y, Li H, Yu G-R, Leem S-H, et al. (2011) Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Experimental & Molecular Medicine 44: 214-224. doi: 10.1371/journal.pone. 0115731 PMID: 25551853
30. Syed V, Mukherjee K, Lyons-Weiler J, Lau K-M, Mashima T, et al. (2005) Identification of ATF-3, caveo-lin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24: 1774-1787. PMID: 15674352
31. Martinez J, Prevot S, Nordlinger B, Nguyen T, Lacarriere Y, et al. (1995) Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37: 712-720. PMID: 8549951
32. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, et al. (1994) Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer research 54: 1825-1830. PMID: 7907945
33. Aktary Z, Chapman K, Lam L, Lo A, Ji C, et al. (2010) Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene 29: 2118-2129. doi: 10.1038/onc.2009.495 PMID: 20101217
34. Polański R, Maguire M, Nield PC, Jenkins RE, Park BK, et al. (2011) MDM2 interacts with NME2 (nonmetastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility. Carcinogenesis 32: 1133-1142. doi: 10.1093/carcin/bgr070 PMID: 21504894
35. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, et al. (2005) Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer research 65: 3136-3145. PMID: 15833843
36. Thakur RK, Kumar P, Halder K, Verma A, Kar A, et al. (2009) Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic acids research 37: 172-183. doi: 10.1093/nar/gkn919 PMID: 19033359
37. Kar A, Saha D, Purohit G, Singh A, Kumar P, et al. (2012) Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells. Nucleic acids research 40: 2554-2565. doi: 10.1093/nar/gkr1109 PMID: 22135295